IL185932A0 - Compositions of hsp60 peptides and viral antigers for vaccination and diagnosis - Google Patents

Compositions of hsp60 peptides and viral antigers for vaccination and diagnosis

Info

Publication number
IL185932A0
IL185932A0 IL185932A IL18593207A IL185932A0 IL 185932 A0 IL185932 A0 IL 185932A0 IL 185932 A IL185932 A IL 185932A IL 18593207 A IL18593207 A IL 18593207A IL 185932 A0 IL185932 A0 IL 185932A0
Authority
IL
Israel
Prior art keywords
antigers
vaccination
viral
diagnosis
compositions
Prior art date
Application number
IL185932A
Other versions
IL185932A (en
Original Assignee
Yeda Res & Dev
Angel Porgador
Herkel Johannes
Cohen Irun R
B G Negev Technologies And App
Rager Zisman Bracha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2006/000222 external-priority patent/WO2006097914A2/en
Application filed by Yeda Res & Dev, Angel Porgador, Herkel Johannes, Cohen Irun R, B G Negev Technologies And App, Rager Zisman Bracha filed Critical Yeda Res & Dev
Priority to IL185932A priority Critical patent/IL185932A/en
Publication of IL185932A0 publication Critical patent/IL185932A0/en
Publication of IL185932A publication Critical patent/IL185932A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IL185932A 2005-03-14 2007-09-11 Viral antigens, conjugates and compositions thereof for vaccination and diagnosis IL185932A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL185932A IL185932A (en) 2005-03-14 2007-09-11 Viral antigens, conjugates and compositions thereof for vaccination and diagnosis

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66101705P 2005-03-14 2005-03-14
PCT/IL2006/000222 WO2006097914A2 (en) 2005-03-14 2006-02-21 Compositions of hsp60 peptides and viral antigens for vaccination and diagnosis
IL185932A IL185932A (en) 2005-03-14 2007-09-11 Viral antigens, conjugates and compositions thereof for vaccination and diagnosis

Publications (2)

Publication Number Publication Date
IL185932A0 true IL185932A0 (en) 2008-01-06
IL185932A IL185932A (en) 2014-02-27

Family

ID=42334299

Family Applications (1)

Application Number Title Priority Date Filing Date
IL185932A IL185932A (en) 2005-03-14 2007-09-11 Viral antigens, conjugates and compositions thereof for vaccination and diagnosis

Country Status (1)

Country Link
IL (1) IL185932A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201300684D0 (en) 2013-01-15 2013-02-27 Apitope Int Nv Peptide

Also Published As

Publication number Publication date
IL185932A (en) 2014-02-27

Similar Documents

Publication Publication Date Title
IL261346A (en) Tissue protective peptides and uses thereof
EP2089053A4 (en) Hpv antigen fusion protein vaccine compositions and uses thereof
GB2429013C (en) Peptides for treatment and diagnosis of autoimmunedisease
PL1940240T3 (en) Protein isolate compositions and uses thereof
ZA200810456B (en) Lyophilized formulations of anti-EGFR antibodies
EP2102355A4 (en) Long acting proteins and peptides and methods of making and using the same
PL1890720T3 (en) Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
IL197501A0 (en) Modifications of cupredoxin derived peptides and methods of use thereof
IL205398A0 (en) New antibodies specific of the ?? - amyloid peptides and their uses as diagnostic agents or drugs
EP2234636A4 (en) Stabilized formulations of peptides and proteins
HK1124344A1 (en) Truncated human papillomavirus type 11 l1 proteins 11 l1
GB0505975D0 (en) Novel use of peptide
EP1893233A4 (en) Therapeutic peptides and vaccines
HK1124343A1 (en) Truncated human papillomavirus type 6 l1 proteins
EP1871786A4 (en) Peptide vaccine for influenza virus
HK1133892A1 (en) Truncated human papillomavirus type 18 l1 proteins
ZA200707970B (en) Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis
ZA201101743B (en) Vaccine comprising protein nmbo964 from meisseria meningitidis
EP2097093A4 (en) Therapeutic and diagnostic peptides
EP1999261A4 (en) The use of protein s fusion for protein solubilization
IL185932A0 (en) Compositions of hsp60 peptides and viral antigers for vaccination and diagnosis
IL195901A0 (en) Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders
ZA200710374B (en) Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
ZA200800566B (en) Therapeutic peptides and vaccines
EP2244725A4 (en) Novel peptides and protein and uses thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees